Immunoconjugate: Difference between revisions
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
||
Line 6: | Line 6: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
Latest revision as of 18:33, 4 September 2012
WikiDoc Resources for Immunoconjugate |
Articles |
---|
Most recent articles on Immunoconjugate Most cited articles on Immunoconjugate |
Media |
Powerpoint slides on Immunoconjugate |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Immunoconjugate at Clinical Trials.gov Trial results on Immunoconjugate Clinical Trials on Immunoconjugate at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Immunoconjugate NICE Guidance on Immunoconjugate
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Immunoconjugate Discussion groups on Immunoconjugate Patient Handouts on Immunoconjugate Directions to Hospitals Treating Immunoconjugate Risk calculators and risk factors for Immunoconjugate
|
Healthcare Provider Resources |
Causes & Risk Factors for Immunoconjugate |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Immunoconjugates are antibodies conjugated to a second molecule, usually a toxin, radioisotope or label.[1] These conjugates are used in immunotherapy and to develop monoclonal antibody therapy as a targeted form of chemotherapy.[2]